Severe Combined Immunodeficiency (SCID) Treatments

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Severe Combined Immunodeficiency (SCID).

Found 1 Approved Drug for Severe Combined Immunodeficiency (SCID)

Revcovi

Generic Name

Elapegademase-Lvlr

Form: Injection

Method of administration: Intramuscular

FDA approval date: October 05, 2018

REVCOVI is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. REVCOVI is a recombinant adenosine deaminase indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. ( 1 )

Showing 1-1 of 1

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Medications for Severe Combined Immunodeficiency (SCID)

Revcovi

Revcovi